Sign in

CIK 0001919246 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Pelthos Therapeutics Inc.

Sign in to watch
Ticker
PTHS
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
NV
Entity type
operating
EIN
863335449
Phone
919-908-2422
Business address
4020 STIRRUP CREEK DRIVE, SUITE 110, DURHAM, NC, 27703
Former names
Channel Therapeutics Corp, Chromocell Therapeutics Corp
  1. S-1/A Offering Registration Statement
  2. CORRESP Other Correspondence Between Filers and SEC Staff
  3. S-1/A Offering Registration Statement
  4. UPLOAD Other SEC-generated Letter
  5. CORRESP Other Correspondence Between Filers and SEC Staff
  6. S-1/A Offering Registration Statement
  7. UPLOAD Other SEC-generated Letter
  8. CORRESP Other Correspondence Between Filers and SEC Staff
  9. S-1/A Offering Registration Statement
  10. UPLOAD Other SEC-generated Letter
  11. S-1/A Offering Registration Statement
  12. CORRESP Other Correspondence Between Filers and SEC Staff
  13. S-1 Offering Registration Statement
  14. UPLOAD Other SEC-generated Letter
  15. DRS/A Other Draft Registration Statement
  16. DRSLTR Other Correspondence Related to Draft Registration Statement
  17. UPLOAD Other SEC-generated Letter
  18. DRS Other Draft Registration Statement

Page 13 of 13 · 258 filings